Scrip
Morgan Stanley urges pipeline-weak big pharma to exit research
21 January 2010
Simon Varcoe
Please Login to read the full article.
21 January 2010
Simon Varcoe
Big pharma's hopes on thriving over the coming years depend on its ability to refocus its business strategies on in-licensed products, rather than in-house research, according to Morgan Stanley analysts.
The cost of bringing a drug to market has risen from an average of $150 million in 1980...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
Today
Cambridge, UK
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
